That study reported a surprising 4.3- and 5.5-fold increased risk of overall mortality and cardiovascular disease-related mortality below ALT 13 IU/L, using ALT 19–23 IU/L as the reference standard [20]. The gene discussed is GPT; the disease is cardiovascular disorder.